IBDEI014 ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2201,1,3,0)
 ;;=3^Sudden idiopathic hearing loss, left ear
 ;;^UTILITY(U,$J,358.3,2201,1,4,0)
 ;;=4^H91.22
 ;;^UTILITY(U,$J,358.3,2201,2)
 ;;=^5006938
 ;;^UTILITY(U,$J,358.3,2202,0)
 ;;=H91.21^^20^171^35
 ;;^UTILITY(U,$J,358.3,2202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2202,1,3,0)
 ;;=3^Sudden idiopathic hearing loss, right ear
 ;;^UTILITY(U,$J,358.3,2202,1,4,0)
 ;;=4^H91.21
 ;;^UTILITY(U,$J,358.3,2202,2)
 ;;=^5006937
 ;;^UTILITY(U,$J,358.3,2203,0)
 ;;=H91.93^^20^171^10
 ;;^UTILITY(U,$J,358.3,2203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2203,1,3,0)
 ;;=3^Hearing Loss,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,2203,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,2203,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,2204,0)
 ;;=H91.91^^20^171^14
 ;;^UTILITY(U,$J,358.3,2204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2204,1,3,0)
 ;;=3^Hearing Loss,Right Ear,Unspec
 ;;^UTILITY(U,$J,358.3,2204,1,4,0)
 ;;=4^H91.91
 ;;^UTILITY(U,$J,358.3,2204,2)
 ;;=^5133553
 ;;^UTILITY(U,$J,358.3,2205,0)
 ;;=H91.92^^20^171^12
 ;;^UTILITY(U,$J,358.3,2205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2205,1,3,0)
 ;;=3^Hearing Loss,Left Ear,Unspec
 ;;^UTILITY(U,$J,358.3,2205,1,4,0)
 ;;=4^H91.92
 ;;^UTILITY(U,$J,358.3,2205,2)
 ;;=^5133554
 ;;^UTILITY(U,$J,358.3,2206,0)
 ;;=H90.6^^20^171^17
 ;;^UTILITY(U,$J,358.3,2206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2206,1,3,0)
 ;;=3^Mixed Conductive & Sensorineural Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,2206,1,4,0)
 ;;=4^H90.6
 ;;^UTILITY(U,$J,358.3,2206,2)
 ;;=^5006924
 ;;^UTILITY(U,$J,358.3,2207,0)
 ;;=H90.71^^20^171^18
 ;;^UTILITY(U,$J,358.3,2207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2207,1,3,0)
 ;;=3^Mixed Conductive & Sensorineural Hearing Loss,Right Ear
 ;;^UTILITY(U,$J,358.3,2207,1,4,0)
 ;;=4^H90.71
 ;;^UTILITY(U,$J,358.3,2207,2)
 ;;=^5006925
 ;;^UTILITY(U,$J,358.3,2208,0)
 ;;=H90.72^^20^171^19
 ;;^UTILITY(U,$J,358.3,2208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2208,1,3,0)
 ;;=3^Mixed Conductive & Sensorineural Hearing Loss,Left Ear
 ;;^UTILITY(U,$J,358.3,2208,1,4,0)
 ;;=4^H90.72
 ;;^UTILITY(U,$J,358.3,2208,2)
 ;;=^5006926
 ;;^UTILITY(U,$J,358.3,2209,0)
 ;;=H90.8^^20^171^20
 ;;^UTILITY(U,$J,358.3,2209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2209,1,3,0)
 ;;=3^Mixed Conductive & Sensorineural Hearing Loss,Unspec
 ;;^UTILITY(U,$J,358.3,2209,1,4,0)
 ;;=4^H90.8
 ;;^UTILITY(U,$J,358.3,2209,2)
 ;;=^5006927
 ;;^UTILITY(U,$J,358.3,2210,0)
 ;;=H90.5^^20^171^27
 ;;^UTILITY(U,$J,358.3,2210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2210,1,3,0)
 ;;=3^Sensorineural Hearing Loss,Unspec
 ;;^UTILITY(U,$J,358.3,2210,1,4,0)
 ;;=4^H90.5
 ;;^UTILITY(U,$J,358.3,2210,2)
 ;;=^5006923
 ;;^UTILITY(U,$J,358.3,2211,0)
 ;;=H90.A11^^20^171^5
 ;;^UTILITY(U,$J,358.3,2211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2211,1,3,0)
 ;;=3^Conductive Hearing Loss,Uni,Right Ear w/ Rstrcd Hear Cntra Side
 ;;^UTILITY(U,$J,358.3,2211,1,4,0)
 ;;=4^H90.A11
 ;;^UTILITY(U,$J,358.3,2211,2)
 ;;=^5138584
 ;;^UTILITY(U,$J,358.3,2212,0)
 ;;=H90.A12^^20^171^4
 ;;^UTILITY(U,$J,358.3,2212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2212,1,3,0)
 ;;=3^Conductive Hearing Loss,Uni,Left Ear w/ Rstrcd Hear Cntra Side
 ;;^UTILITY(U,$J,358.3,2212,1,4,0)
 ;;=4^H90.A12
 ;;^UTILITY(U,$J,358.3,2212,2)
 ;;=^5138585
 ;;^UTILITY(U,$J,358.3,2213,0)
 ;;=H90.A21^^20^171^30
 ;;^UTILITY(U,$J,358.3,2213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2213,1,3,0)
 ;;=3^Snsrnrl Hearing Loss,Uni,Right Ear w/ Rstrcd Hear Cntra Side
 ;;^UTILITY(U,$J,358.3,2213,1,4,0)
 ;;=4^H90.A21
 ;;^UTILITY(U,$J,358.3,2213,2)
 ;;=^5138586
 ;;^UTILITY(U,$J,358.3,2214,0)
 ;;=H90.A22^^20^171^29
 ;;^UTILITY(U,$J,358.3,2214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2214,1,3,0)
 ;;=3^Snsrnrl Hearing Loss,Uni,Left Ear w/ Rstrcd Hear Cntra Side
 ;;^UTILITY(U,$J,358.3,2214,1,4,0)
 ;;=4^H90.A22
 ;;^UTILITY(U,$J,358.3,2214,2)
 ;;=^5138587
 ;;^UTILITY(U,$J,358.3,2215,0)
 ;;=H90.A31^^20^171^16
 ;;^UTILITY(U,$J,358.3,2215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2215,1,3,0)
 ;;=3^Mix Cndct/Snrl Hear Loss,Uni,R Ear w/ Rstrcd Hear Cntra Side
 ;;^UTILITY(U,$J,358.3,2215,1,4,0)
 ;;=4^H90.A31
 ;;^UTILITY(U,$J,358.3,2215,2)
 ;;=^5138588
 ;;^UTILITY(U,$J,358.3,2216,0)
 ;;=H90.A32^^20^171^15
 ;;^UTILITY(U,$J,358.3,2216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2216,1,3,0)
 ;;=3^Mix Cndct/Snrl Hear Loss,Uni,L Ear w/ Rstrcd Hear Cntra Side
 ;;^UTILITY(U,$J,358.3,2216,1,4,0)
 ;;=4^H90.A32
 ;;^UTILITY(U,$J,358.3,2216,2)
 ;;=^5138589
 ;;^UTILITY(U,$J,358.3,2217,0)
 ;;=H83.3X1^^20^172^3
 ;;^UTILITY(U,$J,358.3,2217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2217,1,3,0)
 ;;=3^Noise effects on right inner ear
 ;;^UTILITY(U,$J,358.3,2217,1,4,0)
 ;;=4^H83.3X1
 ;;^UTILITY(U,$J,358.3,2217,2)
 ;;=^5006906
 ;;^UTILITY(U,$J,358.3,2218,0)
 ;;=H83.3X2^^20^172^2
 ;;^UTILITY(U,$J,358.3,2218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2218,1,3,0)
 ;;=3^Noise effects on left inner ear
 ;;^UTILITY(U,$J,358.3,2218,1,4,0)
 ;;=4^H83.3X2
 ;;^UTILITY(U,$J,358.3,2218,2)
 ;;=^5006907
 ;;^UTILITY(U,$J,358.3,2219,0)
 ;;=H83.3X3^^20^172^1
 ;;^UTILITY(U,$J,358.3,2219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2219,1,3,0)
 ;;=3^Noise effects on bilateral inner ear
 ;;^UTILITY(U,$J,358.3,2219,1,4,0)
 ;;=4^H83.3X3
 ;;^UTILITY(U,$J,358.3,2219,2)
 ;;=^5006908
 ;;^UTILITY(U,$J,358.3,2220,0)
 ;;=H55.01^^20^173^1
 ;;^UTILITY(U,$J,358.3,2220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2220,1,3,0)
 ;;=3^Congenital nystagmus
 ;;^UTILITY(U,$J,358.3,2220,1,4,0)
 ;;=4^H55.01
 ;;^UTILITY(U,$J,358.3,2220,2)
 ;;=^5006371
 ;;^UTILITY(U,$J,358.3,2221,0)
 ;;=H55.04^^20^173^2
 ;;^UTILITY(U,$J,358.3,2221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2221,1,3,0)
 ;;=3^Dissociated nystagmus
 ;;^UTILITY(U,$J,358.3,2221,1,4,0)
 ;;=4^H55.04
 ;;^UTILITY(U,$J,358.3,2221,2)
 ;;=^269325
 ;;^UTILITY(U,$J,358.3,2222,0)
 ;;=H55.02^^20^173^3
 ;;^UTILITY(U,$J,358.3,2222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2222,1,3,0)
 ;;=3^Latent nystagmus
 ;;^UTILITY(U,$J,358.3,2222,1,4,0)
 ;;=4^H55.02
 ;;^UTILITY(U,$J,358.3,2222,2)
 ;;=^5006372
 ;;^UTILITY(U,$J,358.3,2223,0)
 ;;=H55.09^^20^173^4
 ;;^UTILITY(U,$J,358.3,2223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2223,1,3,0)
 ;;=3^Nystagmus NEC
 ;;^UTILITY(U,$J,358.3,2223,1,4,0)
 ;;=4^H55.09
 ;;^UTILITY(U,$J,358.3,2223,2)
 ;;=^87599
 ;;^UTILITY(U,$J,358.3,2224,0)
 ;;=H55.81^^20^173^5
 ;;^UTILITY(U,$J,358.3,2224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2224,1,3,0)
 ;;=3^Saccadic eye movements
 ;;^UTILITY(U,$J,358.3,2224,1,4,0)
 ;;=4^H55.81
 ;;^UTILITY(U,$J,358.3,2224,2)
 ;;=^5006373
 ;;^UTILITY(U,$J,358.3,2225,0)
 ;;=H55.03^^20^173^6
 ;;^UTILITY(U,$J,358.3,2225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2225,1,3,0)
 ;;=3^Visual deprivation nystagmus
 ;;^UTILITY(U,$J,358.3,2225,1,4,0)
 ;;=4^H55.03
 ;;^UTILITY(U,$J,358.3,2225,2)
 ;;=^269322
 ;;^UTILITY(U,$J,358.3,2226,0)
 ;;=T36.5X5A^^20^174^1
 ;;^UTILITY(U,$J,358.3,2226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2226,1,3,0)
 ;;=3^Adverse effect of aminoglycosides, initial encounter
 ;;^UTILITY(U,$J,358.3,2226,1,4,0)
 ;;=4^T36.5X5A
 ;;^UTILITY(U,$J,358.3,2226,2)
 ;;=^5049358
 ;;^UTILITY(U,$J,358.3,2227,0)
 ;;=T36.5X5S^^20^174^2
 ;;^UTILITY(U,$J,358.3,2227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2227,1,3,0)
 ;;=3^Adverse effect of aminoglycosides, sequela
 ;;^UTILITY(U,$J,358.3,2227,1,4,0)
 ;;=4^T36.5X5S
 ;;^UTILITY(U,$J,358.3,2227,2)
 ;;=^5049360
 ;;^UTILITY(U,$J,358.3,2228,0)
 ;;=T36.5X5D^^20^174^3
 ;;^UTILITY(U,$J,358.3,2228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2228,1,3,0)
 ;;=3^Adverse effect of aminoglycosides, subsequent encounter
 ;;^UTILITY(U,$J,358.3,2228,1,4,0)
 ;;=4^T36.5X5D
 ;;^UTILITY(U,$J,358.3,2228,2)
 ;;=^5049359
 ;;^UTILITY(U,$J,358.3,2229,0)
 ;;=T45.1X5A^^20^174^5
 ;;^UTILITY(U,$J,358.3,2229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2229,1,3,0)
 ;;=3^Adverse effect of antineoplastic and immunosup drugs, init
 ;;^UTILITY(U,$J,358.3,2229,1,4,0)
 ;;=4^T45.1X5A
 ;;^UTILITY(U,$J,358.3,2229,2)
 ;;=^5051026
 ;;^UTILITY(U,$J,358.3,2230,0)
 ;;=T45.1X5D^^20^174^6
 ;;^UTILITY(U,$J,358.3,2230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2230,1,3,0)
 ;;=3^Adverse effect of antineoplastic and immunosup drugs, subs
 ;;^UTILITY(U,$J,358.3,2230,1,4,0)
 ;;=4^T45.1X5D
 ;;^UTILITY(U,$J,358.3,2230,2)
 ;;=^5051027
 ;;^UTILITY(U,$J,358.3,2231,0)
 ;;=T45.1X5S^^20^174^4
 ;;^UTILITY(U,$J,358.3,2231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2231,1,3,0)
 ;;=3^Adverse effect of antineopl and immunosup drugs, sequela
 ;;^UTILITY(U,$J,358.3,2231,1,4,0)
 ;;=4^T45.1X5S
 ;;^UTILITY(U,$J,358.3,2231,2)
 ;;=^5051028
 ;;^UTILITY(U,$J,358.3,2232,0)
 ;;=T36.8X5A^^20^174^7
 ;;^UTILITY(U,$J,358.3,2232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2232,1,3,0)
 ;;=3^Adverse effect of other systemic antibiotics, init encntr
 ;;^UTILITY(U,$J,358.3,2232,1,4,0)
 ;;=4^T36.8X5A
 ;;^UTILITY(U,$J,358.3,2232,2)
 ;;=^5049412
 ;;^UTILITY(U,$J,358.3,2233,0)
 ;;=T36.8X5D^^20^174^8
 ;;^UTILITY(U,$J,358.3,2233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2233,1,3,0)
 ;;=3^Adverse effect of other systemic antibiotics, subs encntr
 ;;^UTILITY(U,$J,358.3,2233,1,4,0)
 ;;=4^T36.8X5D
 ;;^UTILITY(U,$J,358.3,2233,2)
 ;;=^5049413
 ;;^UTILITY(U,$J,358.3,2234,0)
 ;;=T36.8X5S^^20^174^9
 ;;^UTILITY(U,$J,358.3,2234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2234,1,3,0)
 ;;=3^Adverse effect of other systemic antibiotics, sequela
 ;;^UTILITY(U,$J,358.3,2234,1,4,0)
 ;;=4^T36.8X5S
 ;;^UTILITY(U,$J,358.3,2234,2)
 ;;=^5049414
 ;;^UTILITY(U,$J,358.3,2235,0)
 ;;=T49.6X5A^^20^174^10
 ;;^UTILITY(U,$J,358.3,2235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2235,1,3,0)
 ;;=3^Adverse effect of otorhino drugs and preparations, init
 ;;^UTILITY(U,$J,358.3,2235,1,4,0)
 ;;=4^T49.6X5A
 ;;^UTILITY(U,$J,358.3,2235,2)
 ;;=^5051926
 ;;^UTILITY(U,$J,358.3,2236,0)
 ;;=T49.6X5D^^20^174^11
 ;;^UTILITY(U,$J,358.3,2236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2236,1,3,0)
 ;;=3^Adverse effect of otorhino drugs and preparations, subs
 ;;^UTILITY(U,$J,358.3,2236,1,4,0)
 ;;=4^T49.6X5D
 ;;^UTILITY(U,$J,358.3,2236,2)
 ;;=^5051927
 ;;^UTILITY(U,$J,358.3,2237,0)
 ;;=T49.6X5S^^20^174^12
 ;;^UTILITY(U,$J,358.3,2237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2237,1,3,0)
 ;;=3^Adverse effect of otorhino drugs and preparations, sequela
 ;;^UTILITY(U,$J,358.3,2237,1,4,0)
 ;;=4^T49.6X5S
 ;;^UTILITY(U,$J,358.3,2237,2)
 ;;=^5051928
 ;;^UTILITY(U,$J,358.3,2238,0)
 ;;=T36.95XA^^20^174^13
 ;;^UTILITY(U,$J,358.3,2238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2238,1,3,0)
 ;;=3^Adverse effect of unsp systemic antibiotic, init encntr
 ;;^UTILITY(U,$J,358.3,2238,1,4,0)
 ;;=4^T36.95XA
 ;;^UTILITY(U,$J,358.3,2238,2)
 ;;=^5049430
 ;;^UTILITY(U,$J,358.3,2239,0)
 ;;=T36.95XD^^20^174^14
 ;;^UTILITY(U,$J,358.3,2239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2239,1,3,0)
 ;;=3^Adverse effect of unsp systemic antibiotic, subs encntr
 ;;^UTILITY(U,$J,358.3,2239,1,4,0)
 ;;=4^T36.95XD
 ;;^UTILITY(U,$J,358.3,2239,2)
 ;;=^5049431
 ;;^UTILITY(U,$J,358.3,2240,0)
 ;;=T36.95XS^^20^174^15
 ;;^UTILITY(U,$J,358.3,2240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2240,1,3,0)
 ;;=3^Adverse effect of unspecified systemic antibiotic, sequela
 ;;^UTILITY(U,$J,358.3,2240,1,4,0)
 ;;=4^T36.95XS
 ;;^UTILITY(U,$J,358.3,2240,2)
 ;;=^5049432
 ;;^UTILITY(U,$J,358.3,2241,0)
 ;;=S04.9XXA^^20^174^22
 ;;^UTILITY(U,$J,358.3,2241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2241,1,3,0)
 ;;=3^Injury of unspecified cranial nerve, initial encounter
 ;;^UTILITY(U,$J,358.3,2241,1,4,0)
 ;;=4^S04.9XXA
 ;;^UTILITY(U,$J,358.3,2241,2)
 ;;=^5020573
 ;;^UTILITY(U,$J,358.3,2242,0)
 ;;=R49.8^^20^174^97
 ;;^UTILITY(U,$J,358.3,2242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2242,1,3,0)
 ;;=3^Voice and Resonance Disorders NEC
 ;;^UTILITY(U,$J,358.3,2242,1,4,0)
 ;;=4^R49.8
 ;;^UTILITY(U,$J,358.3,2242,2)
 ;;=^5019505
 ;;^UTILITY(U,$J,358.3,2243,0)
 ;;=T36.5X1A^^20^174^24
 ;;^UTILITY(U,$J,358.3,2243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2243,1,3,0)
 ;;=3^Poisoning by aminoglycosides, accidental, init
 ;;^UTILITY(U,$J,358.3,2243,1,4,0)
 ;;=4^T36.5X1A
 ;;^UTILITY(U,$J,358.3,2243,2)
 ;;=^5049346
 ;;^UTILITY(U,$J,358.3,2244,0)
 ;;=T36.5X1D^^20^174^25
 ;;^UTILITY(U,$J,358.3,2244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2244,1,3,0)
 ;;=3^Poisoning by aminoglycosides, accidental, subs
 ;;^UTILITY(U,$J,358.3,2244,1,4,0)
 ;;=4^T36.5X1D
 ;;^UTILITY(U,$J,358.3,2244,2)
 ;;=^5049347
 ;;^UTILITY(U,$J,358.3,2245,0)
 ;;=T36.5X1S^^20^174^26
 ;;^UTILITY(U,$J,358.3,2245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2245,1,3,0)
 ;;=3^Poisoning by aminoglycosides, accidental, sequela
 ;;^UTILITY(U,$J,358.3,2245,1,4,0)
 ;;=4^T36.5X1S
 ;;^UTILITY(U,$J,358.3,2245,2)
 ;;=^5049348
 ;;^UTILITY(U,$J,358.3,2246,0)
 ;;=T36.5X3A^^20^174^27
 ;;^UTILITY(U,$J,358.3,2246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2246,1,3,0)
 ;;=3^Poisoning by aminoglycosides, assault, initial encounter
 ;;^UTILITY(U,$J,358.3,2246,1,4,0)
 ;;=4^T36.5X3A
 ;;^UTILITY(U,$J,358.3,2246,2)
 ;;=^5049352
 ;;^UTILITY(U,$J,358.3,2247,0)
 ;;=T36.5X3D^^20^174^28
 ;;^UTILITY(U,$J,358.3,2247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2247,1,3,0)
 ;;=3^Poisoning by aminoglycosides, assault, subsequent encounter
 ;;^UTILITY(U,$J,358.3,2247,1,4,0)
 ;;=4^T36.5X3D
 ;;^UTILITY(U,$J,358.3,2247,2)
 ;;=^5049353
 ;;^UTILITY(U,$J,358.3,2248,0)
 ;;=T36.5X3S^^20^174^29
 ;;^UTILITY(U,$J,358.3,2248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2248,1,3,0)
 ;;=3^Poisoning by aminoglycosides, assault, sequela
 ;;^UTILITY(U,$J,358.3,2248,1,4,0)
 ;;=4^T36.5X3S
 ;;^UTILITY(U,$J,358.3,2248,2)
 ;;=^5049354
 ;;^UTILITY(U,$J,358.3,2249,0)
 ;;=T36.5X2A^^20^174^30
 ;;^UTILITY(U,$J,358.3,2249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2249,1,3,0)
 ;;=3^Poisoning by aminoglycosides, intentional self-harm, init
 ;;^UTILITY(U,$J,358.3,2249,1,4,0)
 ;;=4^T36.5X2A
 ;;^UTILITY(U,$J,358.3,2249,2)
 ;;=^5049349
 ;;^UTILITY(U,$J,358.3,2250,0)
 ;;=T36.5X2D^^20^174^31
 ;;^UTILITY(U,$J,358.3,2250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2250,1,3,0)
 ;;=3^Poisoning by aminoglycosides, intentional self-harm, subs
 ;;^UTILITY(U,$J,358.3,2250,1,4,0)
 ;;=4^T36.5X2D
 ;;^UTILITY(U,$J,358.3,2250,2)
 ;;=^5049350
 ;;^UTILITY(U,$J,358.3,2251,0)
 ;;=T36.5X2S^^20^174^32
 ;;^UTILITY(U,$J,358.3,2251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2251,1,3,0)
 ;;=3^Poisoning by aminoglycosides, intentional self-harm, sequela
 ;;^UTILITY(U,$J,358.3,2251,1,4,0)
 ;;=4^T36.5X2S
 ;;^UTILITY(U,$J,358.3,2251,2)
 ;;=^5049351
 ;;^UTILITY(U,$J,358.3,2252,0)
 ;;=T36.5X4A^^20^174^33
 ;;^UTILITY(U,$J,358.3,2252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2252,1,3,0)
 ;;=3^Poisoning by aminoglycosides, undetermined, init encntr
 ;;^UTILITY(U,$J,358.3,2252,1,4,0)
 ;;=4^T36.5X4A
 ;;^UTILITY(U,$J,358.3,2252,2)
 ;;=^5049355
 ;;^UTILITY(U,$J,358.3,2253,0)
 ;;=T36.5X4D^^20^174^34
 ;;^UTILITY(U,$J,358.3,2253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2253,1,3,0)
 ;;=3^Poisoning by aminoglycosides, undetermined, subs encntr
 ;;^UTILITY(U,$J,358.3,2253,1,4,0)
 ;;=4^T36.5X4D
 ;;^UTILITY(U,$J,358.3,2253,2)
 ;;=^5049356
 ;;^UTILITY(U,$J,358.3,2254,0)
 ;;=T36.5X4S^^20^174^35
 ;;^UTILITY(U,$J,358.3,2254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2254,1,3,0)
 ;;=3^Poisoning by aminoglycosides, undetermined, sequela
 ;;^UTILITY(U,$J,358.3,2254,1,4,0)
 ;;=4^T36.5X4S
 ;;^UTILITY(U,$J,358.3,2254,2)
 ;;=^5049357
 ;;^UTILITY(U,$J,358.3,2255,0)
 ;;=T45.1X1A^^20^174^36
 ;;^UTILITY(U,$J,358.3,2255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2255,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, acc, init
 ;;^UTILITY(U,$J,358.3,2255,1,4,0)
 ;;=4^T45.1X1A
 ;;^UTILITY(U,$J,358.3,2255,2)
 ;;=^5051014
 ;;^UTILITY(U,$J,358.3,2256,0)
 ;;=T45.1X1D^^20^174^37
 ;;^UTILITY(U,$J,358.3,2256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2256,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, acc, subs
 ;;^UTILITY(U,$J,358.3,2256,1,4,0)
 ;;=4^T45.1X1D
 ;;^UTILITY(U,$J,358.3,2256,2)
 ;;=^5051015
 ;;^UTILITY(U,$J,358.3,2257,0)
 ;;=T45.1X1S^^20^174^38
 ;;^UTILITY(U,$J,358.3,2257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2257,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, acc, sequela
 ;;^UTILITY(U,$J,358.3,2257,1,4,0)
 ;;=4^T45.1X1S
 ;;^UTILITY(U,$J,358.3,2257,2)
 ;;=^5051016
 ;;^UTILITY(U,$J,358.3,2258,0)
 ;;=T45.1X3A^^20^174^39
 ;;^UTILITY(U,$J,358.3,2258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2258,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, assault, init
 ;;^UTILITY(U,$J,358.3,2258,1,4,0)
 ;;=4^T45.1X3A
 ;;^UTILITY(U,$J,358.3,2258,2)
 ;;=^5051020
 ;;^UTILITY(U,$J,358.3,2259,0)
 ;;=T45.1X3D^^20^174^40
 ;;^UTILITY(U,$J,358.3,2259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2259,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, assault, subs
 ;;^UTILITY(U,$J,358.3,2259,1,4,0)
 ;;=4^T45.1X3D
 ;;^UTILITY(U,$J,358.3,2259,2)
 ;;=^5051021
 ;;^UTILITY(U,$J,358.3,2260,0)
 ;;=T45.1X3S^^20^174^41
 ;;^UTILITY(U,$J,358.3,2260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2260,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, assault, sequela
 ;;^UTILITY(U,$J,358.3,2260,1,4,0)
 ;;=4^T45.1X3S
 ;;^UTILITY(U,$J,358.3,2260,2)
 ;;=^5051022
 ;;^UTILITY(U,$J,358.3,2261,0)
 ;;=T45.1X2A^^20^174^42
 ;;^UTILITY(U,$J,358.3,2261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2261,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, self-harm, init
 ;;^UTILITY(U,$J,358.3,2261,1,4,0)
 ;;=4^T45.1X2A
 ;;^UTILITY(U,$J,358.3,2261,2)
 ;;=^5051017
 ;;^UTILITY(U,$J,358.3,2262,0)
 ;;=T45.1X2D^^20^174^43
 ;;^UTILITY(U,$J,358.3,2262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2262,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, self-harm, subs
 ;;^UTILITY(U,$J,358.3,2262,1,4,0)
 ;;=4^T45.1X2D
 ;;^UTILITY(U,$J,358.3,2262,2)
 ;;=^5051018
 ;;^UTILITY(U,$J,358.3,2263,0)
 ;;=T45.1X2S^^20^174^23
 ;;^UTILITY(U,$J,358.3,2263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2263,1,3,0)
 ;;=3^Poisn by antineopl and immunosup drugs, self-harm, sequela
 ;;^UTILITY(U,$J,358.3,2263,1,4,0)
 ;;=4^T45.1X2S
 ;;^UTILITY(U,$J,358.3,2263,2)
 ;;=^5051019
 ;;^UTILITY(U,$J,358.3,2264,0)
 ;;=T45.1X4A^^20^174^44
 ;;^UTILITY(U,$J,358.3,2264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2264,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, undet, init
 ;;^UTILITY(U,$J,358.3,2264,1,4,0)
 ;;=4^T45.1X4A
 ;;^UTILITY(U,$J,358.3,2264,2)
 ;;=^5051023
 ;;^UTILITY(U,$J,358.3,2265,0)
 ;;=T45.1X4D^^20^174^45
 ;;^UTILITY(U,$J,358.3,2265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2265,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, undet, subs
 ;;^UTILITY(U,$J,358.3,2265,1,4,0)
 ;;=4^T45.1X4D
 ;;^UTILITY(U,$J,358.3,2265,2)
 ;;=^5051024
 ;;^UTILITY(U,$J,358.3,2266,0)
 ;;=T45.1X4S^^20^174^46
 ;;^UTILITY(U,$J,358.3,2266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2266,1,3,0)
 ;;=3^Poisoning by antineopl and immunosup drugs, undet, sequela
